XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB)
Stock · NASDAQ · Health Care
$1.96as of 10/16/2026
Price chart
Active signals
XTLB Signal Track Record
How signals performed across all stocks →What XTLB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 29 | +2.5% | 52% | September 23, 2026 |
| Bollinger Band Breakout | 17 | -5.6% | 24% | August 18, 2026 |
| Volume Spike | 7 | -6.4% | 43% | June 26, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -13.5% | 17% | August 19, 2026 |
| Any 20-session window (baseline) | -4.1% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About XTLB
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the resea…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 4
- Website
- www.xtlbio.com/
Fundamentals
- 1-day range
- $1.98$2.05
- Market cap
- $7.05M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 0.76
- Avg. volume
- 8.2K
- Dividend pay date
- February 10, 2017
XTL Biopharmaceuticals Ltd. American Depositary Shares Competitors
Chosen by industry and closest market cap.
- XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares$1.96▲ 2.62%Market cap $7.05MP/E —$1.6$11.8
- APUSApimeds Pharmaceuticals US Inc. Common Stock$4.04▼ 7.97%Market cap $7.29MP/E —$1.51$403.1
- FBLGFibroBiologics Inc. Common Stock$0.971▼ 2.90%Market cap $6.79MP/E —$0.62$9.65
- ADXNAddex Therapeutics Ltd American Depositary Shares$2.76▼ 8.61%Market cap $7.34MP/E —$0.018$0.069
- CVKDCadrenal Therapeutics Inc. Common Stock$1.09▲ 12.37%Market cap $6.67MP/E —$0.8163$14.35
- BOLTBolt Biotherapeutics Inc. Common Stock$4▼ 5.66%Market cap $7.44MP/E —$3.1$7.2
- IMNNImunon Inc. Common Stock$1.02▼ 3.77%Market cap $6.64MP/E —$0.96$5.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares | $7.05M | — | $1.96 | ▲ 2.62% | $1.6$11.8 |
| APUS Apimeds Pharmaceuticals US Inc. Common Stock | $7.29M | — | $4.04 | ▼ 7.97% | $1.51$403.1 |
| FBLG FibroBiologics Inc. Common Stock | $6.79M | — | $0.971 | ▼ 2.90% | $0.62$9.65 |
| ADXN Addex Therapeutics Ltd American Depositary Shares | $7.34M | — | $2.76 | ▼ 8.61% | $0.018$0.069 |
| CVKD Cadrenal Therapeutics Inc. Common Stock | $6.67M | — | $1.09 | ▲ 12.37% | $0.8163$14.35 |
| BOLT Bolt Biotherapeutics Inc. Common Stock | $7.44M | — | $4 | ▼ 5.66% | $3.1$7.2 |
| IMNN Imunon Inc. Common Stock | $6.64M | — | $1.02 | ▼ 3.77% | $0.96$5.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 72.7K
- Total value held
- $55.5K
- Institutional holders
- 6
- Unknown49.7K
- Unknown13.4K
- Unknown6.0K
- Unknown3.4K
- Unknown244
- Unknown10
See the full, filterable feed with live charts on the MarketWall dashboard.